Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Spotlights Crest With New Packaging, Ad Campaign

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble is unveiling a new uniform packaging scheme for its Crest line that will extend to all products by year end, the company said

You may also be interested in...



Crest WhiteStrips

Retail launch slated for May with ad support to follow, P&G says. About 300,000 kits have been sold over Internet, telephone, QVC since September and in dentists' offices since July for more than $10 mil.; $3.5 mil. in online sales is biggest Web launch for P&G, firm notes (1"The Tan Sheet" Sept. 18, p. 9). P&G estimates whitening kit market at $20 mil.-$25 mil. Drugstore.com offers advance ordering for WhiteStrips to ship May 7 free of mailing charges

Crest WhiteStrips Work In Two Weeks, Last For Six Months - P&G

Procter & Gamble's new Crest WhiteStrips, a do-it-yourself peroxide treatment for whitening teeth, will be available through a special Web site, whitestrips.com, and a toll-free number Sept. 20.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094064

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel